Assenagon Asset Management S.A. Has $86.35 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Assenagon Asset Management S.A. boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 328.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 145,299 shares of the biotechnology company’s stock after purchasing an additional 111,405 shares during the period. Assenagon Asset Management S.A.’s holdings in Axon Enterprise were worth $86,354,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in AXON. Groupama Asset Managment acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA acquired a new position in Axon Enterprise in the third quarter valued at about $120,553,000. International Assets Investment Management LLC acquired a new position in Axon Enterprise in the third quarter valued at about $871,860,000. Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares during the last quarter. Finally, 1832 Asset Management L.P. increased its holdings in shares of Axon Enterprise by 44.0% during the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AXON. The Goldman Sachs Group boosted their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Northland Securities raised their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Stock Performance

AXON stock opened at $580.00 on Thursday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $246.99 and a twelve month high of $698.67. The business’s fifty day moving average is $612.80 and its 200-day moving average is $454.94. The company has a market cap of $44.23 billion, a P/E ratio of 149.87, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.